{"url":"https://newsforagent.com/news/2026-11-17/luminoah-series-b-enteral-feeding","markdown_url":"https://newsforagent.com/news/2026-11-17/luminoah-series-b-enteral-feeding.md","title":"Luminoah Raises $25 Million Series B Led by Sandbox","headline":"Luminoah Raises $25 Million Series B to Expand FDA-Cleared Enteral Feeding System","description":"Luminoah raised $25 million in Series B financing led by Sandbox Clinical Ventures to expand distribution and manufacturing of its FDA-cleared Flow feeding system.","section":"Funding","published_at":"2026-11-17T05:20:04+00:00","modified_at":"2026-11-17T05:20:04+00:00","author":"News Desk","key_takeaways":["Luminoah raised $25 million in Series B financing led by Sandbox Clinical Ventures, comprising $20 million in new equity and $5 million in converted notes.","The Blue Venture Fund, GV, Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund and the AGA GI Opportunity Fund participated in the round.","Luminoah Flow received FDA clearance in April 2026 and began U.S. commercial shipments in July 2026."],"companies":[{"name":"Luminoah","is_primary":true,"profile_url":"https://akta.pro/company-profiles/00026ww/luminoah","website":"https://luminoah.com"},{"name":"Sandbox Industries","is_primary":false,"profile_url":"https://akta.pro/company-profiles/00004fm/sandbox-industries","website":"http://www.sandboxindustries.com"},{"name":"Google Ventures","is_primary":false,"profile_url":"https://akta.pro/company-profiles/00005yr/google-ventures","website":"http://www.gv.com"}],"source":{"publisher":"Pulse 2.0","title":"Luminoah Raises $25 Million Series B To Expand Enteral Feeding Technology","url":"https://pulse2.com/luminoah-raises-25-million-series-b-to-expand-enteral-feeding-technology/"},"other_sources":[],"tags":["Funding","Luminoah","Sandbox Industries","Google Ventures"],"body_markdown":"Luminoah has raised $25 million in Series B financing led by [Sandbox](https://akta.pro/company-profiles/00004fm/sandbox-industries) Clinical Ventures to expand its FDA-cleared enteral feeding system, [Pulse 2.0](https://pulse2.com/luminoah-raises-25-million-series-b-to-expand-enteral-feeding-technology/) reported on November 17, 2026. The round consists of $20 million in new equity and $5 million in previously issued convertible notes that converted as part of the transaction.\n\n## Sandbox Clinical Ventures Leads Luminoah's Series B\n\nThe Blue Venture Fund, GV, Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund and the American Gastroenterological Association GI Opportunity Fund participated alongside existing investors. [Luminoah](https://akta.pro/company-profiles/00026ww/luminoah) will use the capital to expand distribution of Luminoah Flow through home medical equipment suppliers and health systems across the United States. The company also plans to increase production capacity, add manufacturing automation and continue developing Luminoah Intelligence, its data platform for clinicians.\n\nLuminoah Flow received FDA clearance in April 2026, and the company subsequently completed an early-access program involving patients served by healthcare institutions in the Pacific Northwest and Southeast. The system combines a pocket-sized rechargeable feeding pump, nutrition pouches and a connected mobile application. Feeding information is uploaded to the app, and when patients elect to share their data, clinicians can use Luminoah Intelligence to review delivered nutrition and obtain greater visibility into therapy outside clinical settings.\n\n\"For too long, families who depend on tube feeding have had to organize their lives around the pump,\" said Neal Piper, founder and CEO of Luminoah. \"We built Luminoah so the technology could fit around their lives instead.\" Piper created Luminoah after his son, Noah, required tube feeding during cancer treatment. The company was founded in 2020 and is headquartered in Charlottesville, Virginia. It is hiring across engineering, operations and commercial functions as it prepares for broader adoption.\n\n\"We're thrilled to partner with Neal and the Luminoah team to transform enteral feeding,\" said Scott Davis, venture partner at GV. Tom Hawes, managing director at the Blue Venture Fund and Sandbox Clinical Ventures, said Luminoah Flow \"not only improves the patient experience but also directly combats the drivers of poor nutrition plan adherence.\" Garrett Marin, chief operating officer of Luminoah, said the Series B financing enables the company to focus on distribution partners, manufacturing at scale and software clinicians will use.\n\n## Luminoah's Earlier Rounds and Commercial Rollout\n\nAccording to akta.pro [company records](https://akta.pro/company-data), Luminoah's earlier financing includes a $6 million Series A round led by Fry's Path Capital with participation from Sands Capital, CAV Angels, Virginia Venture Partners and 757 Angels, announced in June 2023. The same records list a $463,000 non-dilutive grant from Virginia Catalyst awarded in January 2024 and $25,000 in non-dilutive funding received as a top-five finalist in the MedTech Innovator Early-Stage Grand Prize competition in October 2025. The records also show a December 2025 convertible note of $129,999.\n\n| Round | Date | Amount |\n| --- | --- | --- |\n| Series A | June 2023 | $6 million |\n| Virginia Catalyst grant | January 2024 | $463,000 |\n| MedTech Innovator prize | October 2025 | $25,000 |\n| Convertible note | December 2025 | $129,999 |\n\n## Luminoah Flow's Path to U.S. Shipments\n\nCompany records show Luminoah received FDA 510(k) clearance for the Luminoah Flow Enteral Nutrition System on April 22, 2026, and began commercial rollout and first U.S. shipments of the system in early July 2026. The records also show Luminoah won the inaugural AGA Incubator: Improving GI Care Final Showcase at Digestive Disease Week 2026 in May 2026.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}